159 related articles for article (PubMed ID: 22473906)
1. Hemostatic gelatin sponge is a superior matrix to matrigel for establishment of LNCaP human prostate cancer in nude mice.
Cui L; Chen P; Tan Z; Li W; Dong Z
Prostate; 2012 Nov; 72(15):1669-77. PubMed ID: 22473906
[TBL] [Abstract][Full Text] [Related]
2. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Wilson MJ; Sinha AA
Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix.
Passaniti A; Isaacs JT; Haney JA; Adler SW; Cujdik TJ; Long PV; Kleinman HK
Int J Cancer; 1992 May; 51(2):318-24. PubMed ID: 1568798
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a mouse prostate adenocarcinoma cell line: ductal formation determined by extracellular matrix.
Jorcyk CL; Liu ML; Shibata MA; Maroulakou IG; Komschlies KL; McPhaul MJ; Resau JH; Green JE
Prostate; 1998 Jan; 34(1):10-22. PubMed ID: 9428383
[TBL] [Abstract][Full Text] [Related]
5. Phenoxodiol inhibits growth of metastatic prostate cancer cells.
Aguero MF; Venero M; Brown DM; Smulson ME; Espinoza LA
Prostate; 2010 Aug; 70(11):1211-21. PubMed ID: 20564423
[TBL] [Abstract][Full Text] [Related]
6. Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice.
Gallardo-Williams MT; Chapin RE; King PE; Moser GJ; Goldsworthy TL; Morrison JP; Maronpot RR
Toxicol Pathol; 2004; 32(1):73-8. PubMed ID: 14713551
[TBL] [Abstract][Full Text] [Related]
7. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
8. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
9. The use of matrigel has no influence on tumor development or PET imaging in FaDu human head and neck cancer xenografts.
Fliedner FP; Hansen AE; Jørgensen JT; Kjær A
BMC Med Imaging; 2016 Jan; 16():5. PubMed ID: 26762341
[TBL] [Abstract][Full Text] [Related]
10. Matrigel augments xenograft transplantation of meningioma cells into athymic mice.
Jensen RL; Leppla D; Rokosz N; Wurster RD
Neurosurgery; 1998 Jan; 42(1):130-5; discussion 135-6. PubMed ID: 9442514
[TBL] [Abstract][Full Text] [Related]
11. Reconstituted basement membrane (matrigel) enhances the growth of human glioma cell lines in nude mice.
Akbasak A; Toevs CC; Laske DW
J Neurooncol; 1996 Jan; 27(1):23-30. PubMed ID: 8699222
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice.
El Etreby MF; Liang Y; Johnson MH; Lewis RW
Prostate; 2000 Feb; 42(2):99-106. PubMed ID: 10617866
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of human prostatic carcinoma into nude mice in Matrigel.
Pretlow TG; Delmoro CM; Dilley GG; Spadafora CG; Pretlow TP
Cancer Res; 1991 Jul; 51(14):3814-7. PubMed ID: 2065335
[TBL] [Abstract][Full Text] [Related]
14. Multiple metastases in a novel LNCaP model of human prostate cancer.
Zou M; Jiao J; Zou Q; Xu Y; Cheng M; Xu J; Zhang Y
Oncol Rep; 2013 Aug; 30(2):615-22. PubMed ID: 23446457
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the low pH/low nutrient-resistant LNCaP cell subline LNCaP-F10.
Iguchi K; Hayakawa Y; Ishii K; Matsumoto K; Usui S; Sugimura Y; Hirano K
Oncol Rep; 2012 Dec; 28(6):2009-15. PubMed ID: 22992840
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
17. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.
Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE
Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749
[TBL] [Abstract][Full Text] [Related]
18. The preventative effects of sunitinib malate observed in the course from non-castration to castration LNCaP xenograft prostate tumors.
Jing C; Ning J; Yuanjie N
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2137-43. PubMed ID: 22868821
[TBL] [Abstract][Full Text] [Related]
19. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.
Nadiminty N; Chun JY; Lou W; Lin X; Gao AC
Prostate; 2008 Dec; 68(16):1725-33. PubMed ID: 18781579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
